Abacavir, dolutegravir, and lamivudine

Generic name: Abacavir, Dolutegravir, And Lamivudine
Drug class: Antiviral combinations

Usage of Abacavir, dolutegravir, and lamivudine

Abacavir, dolutegravir, and lamivudine is a combination medicine used to treat human immunodeficiency virus (HIV), the virus that can cause acquired immunodeficiency syndrome (AIDS). abacavir, dolutegravir, and lamivudine is not a cure for HIV or AIDS.

Abacavir, dolutegravir, and lamivudine is for use in adults and children who weigh at least 22 pounds (10 kilograms).

Abacavir, dolutegravir, and lamivudine should not be used by itself in those who are resistant to certain types of medicine.

Abacavir, dolutegravir, and lamivudine may also be used for purposes not listed in this medication guide.

Abacavir, dolutegravir, and lamivudine side effects

Call your doctor at once if you have symptoms of an allergic reaction from two or more of these specific side effect groups:

Group 1 - fever;

Group 2 - rash;

Group 3 - nausea, vomiting, diarrhea, stomach pain;

Group 4 - general ill feeling, extreme tiredness, body aches;

Group 5 - shortness of breath, cough, sore throat.

Once you have had an allergic reaction to a medicine that contains abacavir or dolutegravir, you must never use it again. If you stop taking abacavir, dolutegravir, and lamivudine for any reason, talk to your doctor before you start taking it again.

Abacavir, dolutegravir, and lamivudine may cause serious side effects. Call your doctor at once if you have:

other signs of allergic reaction--skin blisters or peeling, eye redness, swelling in your face or throat, trouble breathing;

lactic acidosis--unusual muscle pain, trouble breathing, stomach pain, vomiting, irregular heart rate, dizziness, feeling cold, or feeling very weak or tired; or

liver problems--swelling around your midsection, right-sided upper stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Abacavir, dolutegravir, and lamivudine affects your immune system, which may cause certain side effects (even weeks or months after you've taken this medicine). Tell your doctor if you have:

signs of a new infection--fever, night sweats, swollen glands, cold sores, cough, wheezing, diarrhea, weight loss;

trouble speaking or swallowing, problems with balance or eye movement, weakness or prickly feeling; or

swelling in your neck or throat (enlarged thyroid), menstrual changes, impotence.

Common side effects of abacavir, dolutegravir, and lamivudine may include:

headache;

tiredness; or

trouble sleeping.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Abacavir, dolutegravir, and lamivudine

You should not use abacavir, dolutegravir, and lamivudine if you are allergic to abacavir, dolutegravir, or lamivudine, or if:

you also take dofetilide (Tikosyn);

you have moderate or severe liver disease;

you have a gene variation called HLA-B*5701 allele (your doctor will test you for this); or

you have a history of allergic reaction to Combivir, Dutrebis, Epivir, Epzicom, Tivicay, Trizivir, or Ziagen.

Tell your doctor if you have ever had:

liver disease (especially hepatitis B or C);

heart problems or risk factors such as diabetes, smoking, high blood pressure, high cholesterol; or

kidney disease.

You may develop lactic acidosis, a dangerous build-up of lactic acid in your blood. This may be more likely if you have other medical conditions, if you are overweight, or if you are a woman. Ask your doctor about your risk.

You may need to have a negative pregnancy test before starting this treatment.

Abacavir, dolutegravir, and lamivudine may harm an unborn baby if you take the medicine at the time of conception or during the first 12 weeks of pregnancy. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.

If you are pregnant, use your medications properly to control your infection. HIV can be passed to your baby if the virus is not controlled during pregnancy. Your name may be listed on a registry to track any effects of antiviral medicine on the baby.

Women with HIV or AIDS should not breast feed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk.

Relate drugs

How to use Abacavir, dolutegravir, and lamivudine

Usual Adult Dose for HIV Infection:

Tablets: 1 tablet orally once a dayComments:-The tablets for oral suspension must not be used in adults.

Usual Pediatric Dose for HIV Infection:

Tablets for Oral Suspension:-Weight 10 to less than 14 kg: 4 tablets orally once a day-Weight 14 to less than 20 kg: 5 tablets orally once a day-Weight 20 to less than 25 kg: 6 tablets orally once a dayTablets:-At least 25 kg: 1 tablet orally once a dayComments:-The tablets are not recommended for patients weighing less than 25 kg.-The tablets for oral suspension are not recommended for patients weighing at least 25 kg.Use: For the treatment of HIV-1 infection

Warnings

You should not take abacavir, dolutegravir, and lamivudine if you have ever had an allergic reaction to any medicine that contains abacavir, or if you have a gene variation called HLA-B*5701 allele. Also, you should not use this medicine if you have moderate or severe liver disease, or if you are also taking dofetilide (Tikosyn).

Stop using this medicine and call your doctor at once if you have any of these signs of an allergic reaction: fever; rash; nausea, vomiting, diarrhea, stomach pain; general ill feeling, extreme tiredness, body aches; shortness of breath, cough, sore throat.

If you've had hepatitis B, it may come back or get worse after you stop using abacavir, dolutegravir, and lamivudine. You may need frequent liver function tests for several months.

What other drugs will affect Abacavir, dolutegravir, and lamivudine

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Some medicines can make abacavir, dolutegravir, and lamivudine much less effective when taken at the same time. If you take any of the following medicines, take your abacavir, dolutegravir, and lamivudine dose 2 hours before or 6 hours after you take the other medicine.

antacids or laxatives that contain aluminum or magnesium (Maalox, Milk of Magnesia, Mylanta, Pepcid Complete, Rolaids, and others);

the ulcer medicine sucralfate (Carafate);

buffered medicine; or

vitamin or mineral supplements that contain calcium or iron (can be taken at the same time with abacavir, dolutegravir, and lamivudine if you take with food).

Many drugs can affect abacavir, dolutegravir, and lamivudine. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

Popular FAQ

To ensure you receive the entire dose of Triumeq, the manufacturer recommends that ideally the tablet be swallowed whole. If you have trouble swallowing a whole tablet, crushing or splitting tablets may be an acceptable alternative, if approved by your healthcare provider. Do not chew, cut, or crush the Triumeq PD tablets. Continue reading

No, Triumeq is not classified as an immunosuppressant. Triumeq is an antiviral medicine used to treat people living with HIV. An immunosuppressant medicine can weaken your immune system and increase your risk of infections or other illnesses. Continue reading

No, Triumeq is not a protease inhibitor. It is a combination integrase inhibitor (dolutegravir) and nucleoside reverse transcriptase inhibitor (abacavir / lamivudine) used in the treatment of people living with HIV. It is used in adults and in children who weigh at least 88 pounds (40 kg). Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.